HomeOpen Access NewsMedical Treatment

Medical Treatment

MHRA approves eplontersen for treating polyneuropathy in adults

The MHRA has approved eplontersen (Wainzua) for treating adults with polyneuropathy associated with hereditary transthyretin amyloidosis.

New research says remdesivir could be used to treat COVID-19

There is more positive news regarding remdesivir, the investigational anti-viral drug that has shown early promise in the fight against COVID-19.

How are different types of medical cannabis working for different diseases?

Dr David Moorhouse, General Neurologist, discusses the way that different diseases respond to different types of medical cannabis.

How cannabinoids can be used as pain medicine

Dr Daniela Tonucci, a consultant for over 10 years, talks us through the use of cannabinoids as pain medicine.

How does research in biochemistry fit into the wider goals of the NIH?

Open Access Government looks into the National Institute of General Medical Sciences (NIGMS)’s Biochemistry and Bio-related Chemistry Branch, and its current research areas and priorities.

Artificial beta cells could lead to new diabetes treatment

Researchers from the University of North Carolina and NC State have developed artificial beta cells that automatically release insulin into the bloodstream when glucose levels rise, leading the way for new diabetes treatment.

The silence before the tsunami: COVID is devastating behind NHS virus frontlines

Doctor Allon Barsam, consultant eye surgeon and founder of Ophthalmic Consultants of London, calls attention to the unexplored devastation behind the NHS virus frontlines.

Globally addressing polypharmacy and multimorbidities with computational techniques

Dr Juliana Bowles, School of Computer Science, University of St Andrews, discusses how to tackle polypharmacy and multimorbidities with computational techniques.

Could placenta cells save patients with severe COVID-19?

Israeli therapeutics firm, Pluristem, have recently pioneered a breakthrough treatment which administers a unique placenta-based cell therapy to COVID-19 patients who have been identified as high-risk mortality cases.

COVID-19 has massively impacted couples struggling with fertility

Sandra Greenbank, Nutritional Therapist & creator of the Corporate Fertility Policy, explores the impact that COVID-19 has had on those struggling with fertility and how employers can offer support.

How to manage acne rosacea in times of stress

Skin conditions often get worse when we are stressed – for example, during the COVID-19 pandemic. Have you just been diagnosed with acne rosacea? Are there any tips or tricks on how to manage it? Here, Dr Deborah Lee, Dr Fox Online Pharmacy, explains everything you need to know.

Scientists design novel chemical compounds using AI to combat SARS-CoV-2

Scientists at TCS designed novel chemical compounds using AI that can inhibit the 3CL protease of SARS-CoV-2, which is responsible for viral replication. Ananth Krishnan, Chief Technology Office, TCS, discusses the research here.

Boosting innovation in the NHS

Innovative technologies have the power to entirely transform the NHS, mitigating the workforce challenges that it faces and transforming the patient experience, whilst improving outcomes, Justin Hall, Vice President and General Manager at iRhythm, discusses here.

Follow these six steps when treating a slipped disc

Here, Neil Velleman of Atkins Physiotherapy Consultants, highlights six steps that you should take when treating a slipped disc.

Can sciatica be treated without surgery?

Dan Plev, Consultant Spinal Neurosurgeon at The London Clinic, discusses how sciatica can be treated with alternative methods when surgery isn't necessary.

Alzheimer’s and dementia funding rises in the U.S.

Rachel Conant, Vice President Federal Affairs, Alzheimer’s Association and Alzheimer’s Impact Movement, provides us with an update on Alzheimer’s and dementia funding rises in the United States.

Eye health: Testing the safety of stem cell therapy for age-related macular degeneration

Kapil Bharti, PhD, Senior Investigator and Head of the Ocular and Stem Cell Translational Research Section at the National Eye Institute (NEI), explains testing the safety of a stem cell therapy for age-related macular degeneration in this special focus on eye health.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders